Client News
Rentschler Biopharma, Cell and Gene Therapy Catapult and Refeyn collaborate to improve process analytical technologies and AAV manufacturing for gene therapies
23rd August 2023
Destiny Pharma: Notice of Interim Results
23rd August 2023
ViGeneron Announces EMA Approval of Clinical Trial Application for VG901, a Gene Therapy to Treat Retinitis Pigmentosa
22nd August 2023
Mainz Biomed Announces Live Launch of ColoAlert® with testDNA Laboratory in Poland
22nd August 2023
Abivax secures up to EUR 150m from two structured debt financing transactions
22nd August 2023
Medigene AG Reports Second Quarter and Six Months 2023 Financial Results and Provides Corporate Update
17th August 2023
Mainz Biomed Announces Financial Half Year Results 2023 and Provides Corporate Update
15th August 2023
InflaRx Reports Second Quarter 2023 Financial Results & Operating Update
10th August 2023
Newron announces H1 2023 results and provides R&D update
4th August 2023
Mainz Biomed Announces Live Launch of ColoAlert® with Marylebone Laboratory in the United Kingdom
1st August 2023
Destiny Pharma: Publication of new data demonstrates significantly superior efficacy of XF-73 compared to a leading topical antibiotic against MRSA in skin infection models
31st July 2023
Tillotts Pharma and TVM Capital Life Science Announce Formation of Mage Biologics to Develop Innovative Oral Antibody Therapy for Ulcerative Colitis
20th July 2023
Destiny Pharma: Board changes including appointment of new CEO
19th July 2023
leon-nanodrugs appoints Dr. Hans Frickel as Chief Executive Officer
18th July 2023
Mainz Biomed Announces Collaboration with Fugene Genetics in Israel
18th July 2023
AATec Medical Announces its Launch with EUR 2.7 million in Seed Financing to Unlock the Therapeutic Potential of Alpha-1 Antitrypsin
17th July 2023
Rentschler Biopharma: Dr. Dominik Kugelstadt joins Rentschler Biopharma as Head of Clinical and Commercial Manufacturing, Laupheim
12th July 2023
Carbios announces the success of its capital increase with preferential subscription rights of approximately 141 million euros, the largest on Euronext Growth since 2015
11th July 2023
Abivax announces the appointment of June Lee, M.D. and Troy Ignelzi as Members of the Board of Directors
11th July 2023
Mallia Therapeutics Secures Seed Funding for its Novel Topical Treatment to Induce Hair Growth via Immune Modulation
11th July 2023
Numaferm and Zoetis Sign License Agreement to Collaborate on Developing and Producing Proteins and Peptides
6th July 2023
AiCuris Announces Strategic Shift to Focus Development and Commercialization of Anti-infectives for Immunocompromised Patients
6th July 2023
Secarna Pharmaceuticals publishes new preclinical data in The Journal of Immunology demonstrating potent therapeutic activity of LNAplus™ ASO targeting NLRP3 in highly debilitating autoinflammatory diseases
6th July 2023
Destiny Pharma: Positive Findings from Recent SAB Meeting
6th July 2023
Destiny Pharma: Business Update
29th June 2023
Mainz Biomed Secures up to $50m in New Funding
29th June 2023
Carbios incorporates its Purpose into company statutes and presents the results of its Special Meeting and Annual General Meeting of 22 June 2023
28th June 2023
InflaRx Appoints Dr. Camilla Chong as Chief Medical Officer
28th June 2023
Affluent Medical Presents Poster on First Successful Procedure with Epygon at the 2023 CSI Conference in Frankfurt
28th June 2023
Mainz Biomed to Attend ESMO World Congress on Gastrointestinal Cancer 2023 in Barcelona, Spain
28th June 2023
Imcyse joins CLAIMS, a European Health Initiative Project to Make Data-Driven Precision Medicine a Reality for Patients with Multiple Sclerosis
22nd June 2023
MIG Capital: MIG Capital co-leads seed investment in French space tech company Look Up Space
22nd June 2023
Carbios announces the launch of a rights issue totalling around €122 million, likely to be increased to around €141 million if the extension clause is fully exercised
22nd June 2023
InflaRx Announces Commercial Launch of Gohibic (vilobelimab) in the U.S. for the Treatment of Critically Ill COVID-19 Patients
21st June 2023
Mainz Biomed Expands into Romania through Partnership with Bioclinica
20th June 2023
